Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system

Authors

Sigrun Hallmeyer, Advocate Aurora HealthFollow
Michael A. Thompson, Advocate Aurora HealthFollow
Veronica Fitzpatrick, Advocate Aurora HealthFollow
Yunqi Liao, Advocate Aurora HealthFollow
Michael P. Mullane, Advocate Aurora HealthFollow
Stephen Medlin, Advocate Aurora HealthFollow
Katherine Cleland, Advocate Aurora HealthFollow
Tulio E Rodriguez, Advocate Aurora HealthFollow
Robert Citronberg, Advocate Aurora HealthFollow
James Weese, Advocate Aurora HealthFollow

Recommended Citation

Hallmeyer S, Thompson MA, Fitzpatrick V, et al. Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system. Journal of Clinical Oncology. 2022;40(16_suppl):e19513.

Affiliations

Aurora Cancer Care, Advocate Aurora Health

Advocate Aurora Health

Aurora Cancer Care

Advocate Lutheran General Hospital

Type

Abstract